64 results
S-3ASR
EX-1.2
IMVT
Immunovant Inc
9 Nov 23
Automatic shelf registration
8:49am
of the Company or any of its subsidiaries, or with the employees of any principal supplier, manufacturer, customer or contractor of the Company, exists
S-3ASR
IMVT
Immunovant Inc
9 Nov 23
Automatic shelf registration
8:49am
are the beneficial owners, but only because they agree to do so in their customer agreements or because they are legally required to do so. Investors who hold
424B5
IMVT
Immunovant Inc
29 Sep 23
Prospectus supplement for primary offering
4:48pm
are the beneficial owners, but only because they agree to do so in their customer agreements or because they are legally required to do so. Investors
8-K
EX-1.1
k4s0g
28 Sep 23
Entry into a Material Definitive Agreement
5:23pm
424B5
6w4i9
26 Sep 23
Prospectus supplement for primary offering
5:28pm
424B5
c5rqs9tot1 vhw7
5 Oct 22
Prospectus supplement for primary offering
4:43pm
8-K
EX-1.1
w5si3ak387fx1uv5a6
4 Oct 22
Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common Stock
5:28pm
8-K
EX-10.1
rgvqe
15 Sep 21
Immunovant Appoints Renee Barnett as Chief Financial Officer
7:23am